Prevalence of neuropathic pain in adolescents with sickle cell disease: A single-center experience.
Melissa CreganLatika PuriGuolian KangDoralina L AnghelescuPublished in: Pediatric blood & cancer (2022)
Overall, in our opinion, NP is not being evaluated for and treated sufficiently in pediatric SCD, especially in the setting of inpatient acute vaso-occlusive crisis. Age and number of acute pain events/admissions in the previous 12 months can be used to identify patients likely to be at risk for NP. It is important to continue to identify NP and develop NP-targeting treatment plans.
Keyphrases
- neuropathic pain
- liver failure
- spinal cord
- spinal cord injury
- newly diagnosed
- end stage renal disease
- respiratory failure
- ejection fraction
- young adults
- sickle cell disease
- public health
- chronic kidney disease
- chronic pain
- physical activity
- mental health
- risk factors
- palliative care
- prognostic factors
- combination therapy
- drug delivery
- acute care
- smoking cessation